MAPT and Cognitive impairment: Pathological changes in amyloid metabolism is a hallmark trait of AD.84 It has been shown that AD-related cognitive impairment usually accompanies reduced CSF Aβ42 levels.85, –87 Conversely, tau protein is implicated in stabilizing functions for several cytoskeletal proteins and regulates their assembly.